Cas:123997-64-8 DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide manufacturer & supplier

We serve Chemical Name:DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide CAS:123997-64-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide

Chemical Name:DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide
CAS.NO:123997-64-8
Synonyms:(1’R,2R,4’S,5S,6R,8’R,10’E,12’S,13’S,14’E,16’E,20’R,21’R)-6-[(2S)-2-Butanyl]-21′,24′-dihydroxy-5,11′,13′,22′-tetramethyl-2′-oxo-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19]trioxatetracyclo[15.6.1.14,8 .020,24]pentacosa[10,14,16,22]tetraen]-12′-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside
Molecular Formula:C41H62O11
Molecular Weight:730.924
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:861.1±65.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.570
PSA:
Exact Mass:730.429199
LogP:5.81

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (1’R,2R,4’S,5S,6R,8’R,10’E,12’S,13’S,14’E,16’E,20’R,21’R)-6-[(2S)-2-Butanyl]-21′,24′-dihydroxy-5,11′,13′,22′-tetramethyl-2′-oxo-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19]trioxatetracyclo[15.6.1.14,8 .020,24]pentacosa[10,14,16,22]tetraen]-12′-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1’R,2R,4’S,5S,6R,8’R,10’E,12’S,13’S,14’E,16’E,20’R,21’R)-6-[(2S)-2-Butanyl]-21′,24′-dihydroxy-5,11′,13′,22′-tetramethyl-2′-oxo-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19]trioxatetracyclo[15.6.1.14,8 .020,24]pentacosa[10,14,16,22]tetraen]-12′-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1’R,2R,4’S,5S,6R,8’R,10’E,12’S,13’S,14’E,16’E,20’R,21’R)-6-[(2S)-2-Butanyl]-21′,24′-dihydroxy-5,11′,13′,22′-tetramethyl-2′-oxo-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19]trioxatetracyclo[15.6.1.14,8 .020,24]pentacosa[10,14,16,22]tetraen]-12′-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside Use and application,(1’R,2R,4’S,5S,6R,8’R,10’E,12’S,13’S,14’E,16’E,20’R,21’R)-6-[(2S)-2-Butanyl]-21′,24′-dihydroxy-5,11′,13′,22′-tetramethyl-2′-oxo-3,4,5,6-tetrahydrospiro[pyran-2,6′-[3,7,19]trioxatetracyclo[15.6.1.14,8 .020,24]pentacosa[10,14,16,22]tetraen]-12′-yl 2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranoside technical grade,usp/ep/jp grade.


Related News: Covington has handled dozens of cases for Lilly over the past 20 years, according to the Westlaw database of legal cases and press releases, including intellectual property matters, personal injury lawsuits and class actions. DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide manufacturer In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed. DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide supplier Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide vendor Covington has handled dozens of cases for Lilly over the past 20 years, according to the Westlaw database of legal cases and press releases, including intellectual property matters, personal injury lawsuits and class actions. DihydroaverMectin B1 Monosaccharide, IverMectin B1 Monosaccharide factory From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.